Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1989-10-18
|
pubmed:abstractText |
In order to clarify the differential activation of CD4+ and CD8+ HSV-specific CTL, we compared the characteristics of CTL generated by different methods of in vitro HSV stimulation by treatment of effectors with anti-CD4 and anti-CD8 mAb and C after the elimination of nonspecific cytotoxic effector cells. Cell-free HSV mainly activated CD4+ CTL precursors, whereas HSV-infected fibroblasts were more effective in activating CD8+ CTL precursors than CD4+ CTL precursors. In addition, limiting dilution analyses with enriched T cells from two HSV-seropositive donors revealed that the frequency of HSV-specific CD4+ CTL precursors responsive to stimulation with free HSV was approximately 1/4,000 to 6,000 CD4+ T cells, whereas that of precursors responsive to stimulation with HSV-infected fibroblasts was approximately 1/19,000 to 22,000 CD4+ T cells. Conversely, the frequency of CD8+ CTL precursors in peripheral blood responsive to stimulation with free HSV was approximately 1/28,000 to 30,000 CD8+ T cells, whereas that of precursors responsive to stimulation with HSV-infected fibroblasts was approximately 1/10,000 to 11,000 CD8+ T cells. The present data suggest that generalized viral infection due to cell-free viruses is fought mainly by CD4+ CTL, which have previously been reported to possess both cytotoxicity and helper function, and that localized viral infection on HLA class II-negative fibroblasts is prevented from spreading to adjacent cells mainly by CD8+ CTL. Such differential activation of CD4+ and CD8+ CTL seems probable when considering the protective mechanisms against viral infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
143
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2051-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2476493-Antibodies, Monoclonal,
pubmed-meshheading:2476493-Antigens, Viral,
pubmed-meshheading:2476493-CD4-Positive T-Lymphocytes,
pubmed-meshheading:2476493-Complement System Proteins,
pubmed-meshheading:2476493-Cytotoxicity, Immunologic,
pubmed-meshheading:2476493-Epitopes,
pubmed-meshheading:2476493-Humans,
pubmed-meshheading:2476493-Leukocyte Count,
pubmed-meshheading:2476493-Lymphocyte Activation,
pubmed-meshheading:2476493-Phenotype,
pubmed-meshheading:2476493-Simplexvirus,
pubmed-meshheading:2476493-Stem Cells,
pubmed-meshheading:2476493-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:2476493-T-Lymphocytes, Regulatory
|
pubmed:year |
1989
|
pubmed:articleTitle |
Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.
|
pubmed:affiliation |
First Department of Internal Medicine, Ehime University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|